In lung cancer cells, CUDC-907 initiated G2/M phase arrest through reducing the expression of cell cycle regulatory proteins as Cdc25C, CdC2, and Cyclin B1, and by elevating p21 protein level. This evidence concerns the gene CDC25C and lung cancer.